General - Press Releases

Date	Title	Company
19-Dec-2023	Global Dairy Flavors Market Trends Analysis and Forecast To 2028 - AI in Flavor Development, Plant-Based Alternatives and Enzyme-Modified Dairy Flavors - ResearchAndMarkets.com	Businesswire
19-Dec-2023	Global Semiconductor Equipment Market Forecast Report to 2026 - Consumer Electronics Boom Drives Explosive Growth - ResearchAndMarkets.com	Businesswire
19-Dec-2023	Innovaderm, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study	Businesswire
19-Dec-2023	AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions	Businesswire
19-Dec-2023	Elligo Health Research Announces New CEO	Businesswire
19-Dec-2023	Biosynth bietet nach Übernahme von VIO Chemicals künftig komplexe chemische Lösungen in größerem Maßstab an	Businesswire
19-Dec-2023	FDA Grants Priority Review to Xolair (omalizumab) for Children and Adults With Food Allergies Based on Positive National Institutes of Health Phase III Study Results	Businesswire
19-Dec-2023	Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s	Businesswire
19-Dec-2023	ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology	Businesswire
19-Dec-2023	1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director	Businesswire
19-Dec-2023	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements	Businesswire
19-Dec-2023	World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States	Businesswire
19-Dec-2023	MBrace Therapeutics Announces Initiation of Patient Dosing in Phase 1 Clinical Trial Evaluating Investigational Antibody-Drug Conjugate MBRC-101	Businesswire
19-Dec-2023	Evaxion Biotech Announces Private Placement Financing	Evaxion Biotech A/S
19-Dec-2023	Boston Pharmaceuticals Appoints Juan Carlos Lopez-Talavera, MD, PhD, as Acting Chief Medical Officer as MASH Asset BOS-580 Accelerates in Phase 2 Clinical Program	Businesswire
19-Dec-2023	Lassen Therapeutics Announces Closing of Oversubscribed $85 Million Series B Financing and Announces First Patient Dosed in the Phase 1 Trial Evaluating LASN01 in Thyroid Eye Disease	Businesswire
19-Dec-2023	Infinimmune Announces Partnership with Grid Therapeutics to Conduct Deep Sequencing of B Cells for Oncology Drug Discovery	Businesswire
19-Dec-2023	Tevogen Bio Expands Presence in Rapidly Emerging Field of Biotechnology AI: Files Patent Applications Related to AI-Driven T cell Target Identification and Receptor Engagement	Businesswire
19-Dec-2023	Premium Audio Brand Master & Dynamic Launch New Era of Smart Audio Products Powered by Neurotechnology Leader Neurable Inc.	Businesswire
19-Dec-2023	Revvity to Present at J.P. Morgan Healthcare Conference	Businesswire